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Abstract
Background: Glial cells, including microglia and astrocytes, are considered the primary source of proinflammatory
cytokines in the brain. Immune insults stimulate glial cells to secrete proinflammatory cytokines that modulate the
acute systemic response, which includes fever, behavioral changes, and hypothalamic-pituitary-adrenal (HPA) axis
activation. We investigated the effect of general anesthetics on proinflammatory cytokine expression in the primary
cultured glial cells, the microglial cell line BV-2, the astrocytic cell line A-1 and mouse brain.
Methodology/Principal Findings: Primary cultured glial cells were exposed to lipopolysaccharide (LPS) in
combination with general anesthetics including isoflurane, pentobarbital, midazolam, ketamine, and propofol.
Following this treatment, we examined glial cell expression of the proinflammatory cytokines interleukin (IL)-1β, IL-6,
and tumor necrosis factor-alpha (TNF-α). LPS-induced expression of IL-1β mRNA and protein were significantly
reduced by all the anesthetics tested, whereas IL-6 and TNF-α mRNA expression was unaffected. The anesthetics
suppressed LPS-induced extracellular signal-regulated kinase 1/2 (ERK 1/2) phosphorylation, but did not affect
nuclear factor-kappaB and activator protein-1 activation. The same effect was observed with BV-2, but not with A-1
cells. In the mouse experiments, LPS was injected intraperitoneally, and isoflurane suppressed IL-1β in the brain and
adrenocorticotropic hormone in plasma, but not IL-1β in plasma.
Conclusions/Significance: Taken together, our results indicate that general anesthetics inhibit LPS-induced IL-1β
upregulation in glial cells, particularly microglia, and affects HPA axis participation in the stress response.
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Introduction
Humans and animals respond rapidly to infection by
activating their innate immune system. Immune-related
messages relayed from the periphery to the brain activate
neural pathways that regulate the acute phase response, which
includes fever, behavioral depression, and hypothalamic-
pituitary-adrenal (HPA) axis activation [1]. These responses,
which are organized to fight against the infection, are triggered
by proinflammatory cytokines such as interleukin (IL)-1β, tumor
necrosis factor-alpha (TNF-α), and IL-6. These cytokines are
secreted by activated neutrophils and monocytes that contact
the invading microorganisms [2]. Peripheral immune signals
are communicated to the brain by neural or humoral routes [3].
The neural route is mediated by the vagus nerve, which
includes sensory neurons that express IL-1 receptors [4]. The
humoral route stimulates brain regions that lack the blood–
brain barrier and react to cytokines or pathogen-associated
molecular patterns [3]. These responses begin in the
circumventricular organs or choroid plexus and then diffuse to
other brain regions [3]. Information transmitted over either
pathway causes the brain to produce same kind of
proinflammatory cytokines produced in periphery [5]. Among
these cytokines, IL-1β is considered the primary regulator of
the systemic response to infection. Central administration of
IL-1β induces all components of the acute phase reaction,
including fever, HPA axis activation, and behavioral depression
[6], whereas IL-6 has no behavioral activity [7].
Glial cells, including microglia and astrocytes, are the
primary source for proinflammatory cytokines in the brain.
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Microglia are resident macrophage-like cell population and are
considered to play a pivotal role in the brain’s innate immune
response [8]. Under normal conditions, microglia are quiescent
and scattered [9]. Occasionally, microglia are moderately
activated as scavengers to maintain and restore the brain [10].
In the case of systemic infection, microglia are activated and
release proinflammatory cytokines to initiate acute
inflammatory responses. Minocycline, a microglial inhibitor,
attenuates lipopolysaccharide (LPS)-induced sickness
behaviors [11]. According to a recent report, astrocytes can
release proinflammatory molecules and modulate immune
responses [12]. Therefore, microglia and astrocytes are
considered major components that mediate immune responses
and inflammation in the brain [13].
In clinical settings, general anesthetics are typically
administered to infectious patients for surgical procedures, but
also for sedation with critical care. Ketamine and
dexmedetomidine can inhibit LPS-induced microglial activation;
however, few studies have examined whether general
anesthetics affect the ability of glial cells to produce
proinflammatory cytokines [9,14]. In addition, the effect of
anesthetics on astrocyte cytokine production is poorly
understood. Recently, we reported that various general
anesthetics also inhibit glial cell production of erythropoietin
under hypoxic conditions, which suggests that general
anesthetics have a common direct effect on glial cell functions
[15]. Therefore, in the present study, we investigated the
effects of several general anesthetics, including isoflurane,
pentobarbital, midazolam, ketamine, and propofol, on LPS-
induced upregulation of proinflammatory cytokines in primary
cultured glial cells. Considering the pivotal role that
proinflammatory cytokines play during the brain’s acute
inflammation phase, the influence of general anesthetics on
cytokine production from glial cells may change the systemic
response to infection involving HPA axis. Therefore, we
performed an additional experiment in vivo in which we
intraperitoneally injected mice with LPS. We then evaluated
cytokine induction in the brain and adrenocorticotropic
hormone (ACTH) concentration in plasma to determine
whether general anesthetics affected the systemic response to
infection.
Results
Anesthetics suppress LPS-induced upregulation of
IL-1β mRNA and protein in primary cultured glial cells
Primary cultured glial cells were exposed to LPS (1 µg/ml)
with propofol or isoflurane for 4 h. LPS exposure significantly
induced IL-1β mRNA upregulation, which was suppressed by
propofol and isoflurane (Figure 1A-C). LPS induced IL-6 and
TNF-α mRNA upregulation, but isoflurane and propofol failed to
suppress their induction, except with a propofol concentration
of 100 µM that suppressed IL-6 induction (Figure 1D-G). Next,
to examine whether the effects of propofol and isoflurane was
observed with other general anesthetics, we exposed glial cells
to LPS with pentobarbital, midazolam, and ketamine. As with
propofol and isoflurane, these anesthetics suppressed LPS-
induced IL-1β upregulation (Figure 2A–C). To determine
whether these effects changed over time, we performed the
same experiments at 2, 8, and 24 h. At 2 h and 8 h, all
anesthetics suppressed LPS-induced IL-1β induction (Figure
2D–F). To investigate the IL-1β induction at the protein level,
we analyzed IL-1β protein accumulation in whole cell lysates
obtained from glial cells. An immunoblot assay showed
remarkable induction of IL-1β protein with LPS, and its
expression was significantly suppressed with isoflurane,
propofol, and pentobarbital (Figure 3A). Finally, IL-1β protein
secretion in medium was assayed with enzyme-linked
immunosorbent assay (ELISA). As shown in Figure 3B, IL-1β
protein concentration in cultured medium was significantly
elevated after a 4-h LPS exposure (1 µg/ml), and the
anesthetics propofol, pentobarbital, midazolam, and ketamine
suppressed this elevation.
Propofol, isoflurane, and pentobarbital inhibit LPS-
induced phosphorylation of ERK, but do not affect NF-
κB or AP-1 activation
LPS activates nuclear factor-kappaB (NF-κB), activator
protein-1 (AP-1), and mitogen-activated protein kinases
(MAPKs), which have been implicated in proinflammatory
cytokine release [16,17]. To investigate the mechanism through
which anesthetics suppress LPS-induced IL-1β upregulation,
we examined the influence of anesthetics on NF-κB and AP-1
activity in glial cells. NFκB and AP-1 transcription quantified
with an ELISA-based kit was significantly elevated with LPS
exposure, and propofol, pentobarbital, and isoflurane failed to
suppress such activity (Figure 4A, B). Next, we examined
MAPK activity in glial cells, which revealed three major MAPK
signaling molecules: extracellular signal-regulated kinase 1/2
(ERK 1/2), c-Jun N-terminal protein kinase (JNK), and p38
MAPK. Based on these findings, we performed a western blot
analysis using the phospho- or total form antibodies against
ERK 1/2, JNK, and p38 MAPK. We observed that propofol,
pentobarbital, and isoflurane remarkably decreased LPS-
stimulated phosphorylation of ERK1/2 at 4 h, but had no effect
on total ERK 1/2 expression (Figure 4C). Anesthetics had no
effect on phosphorylation or total expression of JNK or p38
MAPK (Figure 4C). Finally, in order to examine ERK
involvement in LPS-induced IL-1β upregulation, the ERK
inhibitor PD98059 was added to the cultured glial cells. As
shown in Figure 4D, PD98059 remarkably suppressed LPS-
induced IL-1β mRNA upregulation, and the anesthetics
pentobarbital and propofol did not exert an additive effect with
PD98059. In contrast, PD98059 did not suppress LPS-induced
TNF-α mRNA upregulation (Figure 4E).
Propofol and isoflurane suppress LPS-induced
upregulation of IL-1β mRNA in the BV-2 microglial cell
line, but not in the A-1 astrocytic cell line
For this experiment, we used cultures that included
astrocytes, oligodendrocytes, neurons, microglia, and
ependymal cells, although astrocytes were the predominant
cell type [18]. Microglia and astrocytes are considered
candidates for the source of proinflammatory cytokines, [19].
As is shown in Figure 3B, we detected in an immunoblot the
astroglial marker, glial fibrillary acidic protein (GFAP), and the
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Figure 1.  Effects of propofol and isoflurane on proinflammatory cytokine expression in cultured glial cells.  Primary
cultured glial cells were exposed for 4 hours to lipopolysaccharide (LPS) (1 µg/ml) and propofol or isoflurane at the indicated
concentrations. Interleukin (IL)-1β (A, B, C), IL-6 (D, E), and tumor necrosis factor-alpha (TNF-α) (F, G) mRNA were assayed with
real-time RT-PCR. Data are presented as mean ± SD (n = 4). The expression levels of IL-1β, IL-6, and TNF-α were normalized to
that of 18S, and were expressed relative to the control mean. *P < 0.05 versus control, N.S., not significant (Mann–Whitney U-test).
doi: 10.1371/journal.pone.0082930.g001
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Figure 2.  Effects of anesthetics on LPS-induced IL-1β upregulation in cultured glial cells.  Primary cultured glial cells were
exposed for 4 hours to LPS (1 µg/ml) in the presence of pentobarbital (A), midazolam (B), or ketamine (C) at the indicated
concentrations, or in the presence of propofol (200 µM), ketamine (1 mM), pentobarbital (1 mM), midazolam (150 µM), or isoflurane
(1.5%) for 2 (D), 8 (E), or 24 (F) hours. IL-1β mRNA was assayed with real-time RT-PCR. Data are presented as mean ± SD (n = 6).
The expression levels of IL-1β were normalized to that of 18S and expressed relative to the control mean. *P < 0.05 versus control,
# P < 0.05 versus LPS, N.S., not significant (Mann–Whitney U-test).
doi: 10.1371/journal.pone.0082930.g002
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Figure 3.  Effects of anesthetics on LPS-induced IL-1β protein expression and secretion in cultured glial cells.  Primary
cultured glial cells were exposed for 4 hours to LPS (1 µg/ml) with or without 1.5% isoflurane, 100 µM propofol, or 1 mM
pentobarbital. (A) Whole cell lysates were analyzed for IL-1β, glial fibrillary acidic protein (GFAP), ionized calcium-binding adapter
molecule 1 (IBA-1), and β-actin protein expression by immunoblot assay. Figures are representative of at least three independent
experiments. (B) IL-1β protein concentration in cultured medium was measured with ELISA. Data are presented as mean ± SD (n =
3). *P < 0.05 versus control (Mann–Whitney U-test).
doi: 10.1371/journal.pone.0082930.g003
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Figure 4.  Mechanism underlying inhibitory effect of anesthetics on IL-1β upregulation in LPS-treated cultured glial
cells.  (A, B) Effect of anesthetics on nuclear factor-kappaB (NF-κB) and activator protein-1 (AP-1) transcription in LPS-treated
cultured glial cells. Primary cultured glial cells were exposed to LPS (1 µg/ml) with or without 100 µM propofol, 1 mM pentobarbital,
or 1.5% isoflurane for 4 h. NF-κB (A) and AP-1 (B) transcriptional activities were measured with an ELISA-based kit. Data are
presented as mean ± SD (n = 3). *P < 0.05 versus control. No statistically significant difference was found between any two groups
except with the control. (Mann–Whitney U-test) (C) Effect of anesthetics on activity of MAPK families in LPS-treated cultured glial
cells. Primary cultured glial cells were exposed to LPS (1 µg/ml) with or without 1.5% isoflurane, 100 µM propofol, or 1 mM
pentobarbital for 4 hours. Whole cell lysates were analyzed for extracellular signal-regulated kinase (ERK), phospho-ERK (p-ERK),
phospho-JNK (p-JNK), JNK, phospho-p38 (p-p38), and p38 MAPK expression by immunoblot assay. Figures are representative of
at least three independent experiments. (D, E) Effect of PD98059, an antagonist of ERK 1/2, on IL-1β and TNF-α expression in
LPS-treated cultured glial cells. IL-1β and TNF-α mRNA was assayed with real-time RT-PCR. Primary cultured glial cells were
exposed to LPS (1 µg/ml) and 50 µM PD98059 (PD) with or without 100 µM propofol or 1 mM pentobarbital, and harvested for 4 h.
IL-1β and TNF-α mRNA was assayed with real-time RT-PCR. Data are presented as mean ± SD (n = 3). The expression levels of
IL-1β and TNF-α were normalized to that of 18S and expressed relative to the mean of control. *P < 0.05 versus control, N.S., not
significant (Mann–Whitney U-test).
doi: 10.1371/journal.pone.0082930.g004
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microglial marker, ionized calcium-binding adapter molecule 1
(IBA-1). However, the neuron marker, neuronal nuclei, was not
detected (data not shown). To determine which cells are the
primary sources of cytokines and the cells affected by general
anesthetics, we performed the same series of experiments in
the BV-2 microglial and A-1 astroglial cell lines. In BV-2 cells,
LPS exposure significantly induced IL-1β mRNA, but propofol
and isoflurane suppressed its induction (Figure 5A, B). In
contrast, LPS-induced upregulation of IL-1β was not confirmed
in A-1 cells, although pentobarbital (1 mM) slightly suppressed
IL-1β mRNA levels (Figure 5C). Finally, to determine the effect
of anesthetics on IL-1β induction by hematopoietic cells, we
used the human monocytic cell line THP-1. Following
differentiation with phorbol-12-myristate-13-acetate (PMA),
THP-1 cells showed significant induction of IL-1β mRNA with
LPS, and pentobarbital and isoflurane suppressed this
induction, but to a lesser extent than was observed with BV-2
cells (Figure 5D). THP-1 without PMA did not show IL-1β
mRNA induction with LPS (data not shown).
Isoflurane inhibits IL-1β expression in the mouse brain
after LPS treatment
To examine the effect of general anesthetics on IL-1β
expression in the brain, we intraperitoneally injected LPS (5
mg/kg) in 10-week-old C57BL/6N mice that were subsequently
exposed to 0.5% isoflurane for 4 h. LPS treatment significantly
increased IL-1β mRNA expression, whereas isoflurane
suppressed LPS-induced IL-1β expression in the hypothalamus
(Figure 6A) and cortex (Figure 6B). To confirm the effects of
isoflurane at the protein level, we measured IL-1β protein
concentration in the brains using ELISA. LPS treatment
induced a significant increase in IL-1β protein in the whole
brain 4 h after the LPS treatment, and isoflurane exposure
significantly suppressed its induction (Figure 6C). However,
IL-1β protein concentration in plasma was not elevated at the 4
h time point, and the effect of isoflurane was not apparent
(Figure 6D). Because IL-1β was linked to HPA axis activation
[20], we examined whether anesthetics affected the HPA axis.
We measured serum ACTH levels and found a significant
increase 4 h after the LPS treatment and that isoflurane
exposure significantly suppressed the ACTH elevation (Figure
6E).
Discussion
Glial cells, including astrocytes and microglia, are the major
components that mediate immune responses and inflammation
in the brain [21,22]. Glial cells can produce cytokines, reactive
oxygen radicals, and nitric oxide in response to infectious
insults [23]. In the current study, we demonstrated that
anesthetics, including propofol, isoflurane, ketamine,
pentobarbital, and midazolam, inhibit the induction of IL-1β
from glial cells stimulated with LPS. The same effect was
confirmed with the BV-2 microglial cell line. Microglia are the
main source of inflammatory cytokines in the brain [24].
Therefore, our results suggest that anesthetics exert their IL-1β
inhibitory effect through a direct effect on microglia. Although
several reports indicate anesthetics affect microglia secretion
of proinflammatory cytokines [9,14,23,25], the results vary
among the types of cytokines or stimulation methods. For
example, isoflurane exposure increased the level of the
proinflammatory cytokine IL-1β in the mice brain [25], whereas
ketamine suppressed LPS-induced TNF-α production in
cultured microglia [23]. We found the anesthetics examined in
the present study inhibited IL-1β secretion from LPS-stimulated
glial cells. Dexmedetomidine [14] and ketamine [9] were
reported to have the same effect as isoflurane. Therefore, most
clinically used anesthetics have a similar suppressive effect on
glial cell induction of IL-1β. The primary target of general
anesthetics depends on the anesthetic. For example, ketamine
acts on N-methyl-D-aspartate receptors [26,27], whereas the
volatile anesthetics, propofol and the barbiturates, act on γ-
aminobenzoic acid-A receptors [28,29]. On the other hand, the
action of general anesthetics on glial cells is poorly understood.
Our finding that general anesthetics have an IL-1β-suppressive
effect in vitro indicates that general anesthetics have a
common effect on glial cells, particularly microglia. This finding
is surprising considering the diverse mechanisms of general
anesthetics.
MAPKs have been shown to play an important role in LPS-
induced proinflammatory cytokine release [30]. Therefore, we
investigated the effect of anesthetics on the activation of three
MAPKs and found that the LPS-induced phosphorylation of
ERK1/2 in glial cells treated with LPS was suppressed with
propofol, isoflurane, and pentobarbital. In contrast,
phosphorylation of JNK or p38 MAPK was not affected with
LPS or anesthetics. The reason why LPS failed to activate JNK
and p38 MAPK may be because the duration of LPS exposure
in our experiments (4 h) was too long. In previous reports,
activation was observed with less incubation time [31]. In
addition, the ERK1/2 inhibitor PD98059 dramatically inhibited
LPS-induced IL-1β expression, and anesthetics failed to show
additive effects. This result indicates that ERK 1/2 activation
mainly regulated IL-1β induction in LPS-stimulated glial cells in
our experiment and that anesthetics typically exert their
inhibitory effect by inhibiting ERK 1/2 phosphorylation. On the
other hand, the transcription factors NF-κB and AP-1 regulate
inflammatory cytokine transcription [32]. Therefore, we
investigated the transcriptional activity of NF-κB and AP-1 with
an ELISA-based kit in LPS-stimulated glial cells. LPS treatment
induced NF-κB and AP-1 activation, but anesthetics did not
inhibit their activation. The effect of anesthetics on NF-κB and
AP-1 are not well studied, although isoflurane is reported to
suppress NF-κB activity in a reperfusion model of the mouse
kidney [33].
Recent reports focus on the importance of inflammasome, a
multiprotein platform that activates caspase 1, in regulating of
IL-1β processing and secretion [34–36]. Inflammasome is a
multiprotein oligomer that is comprised of a Nod-like receptor
(NLR) family, which includes NLRP3, the cytosolic receptor
AIM2, and pro-caspase-1 [34]. NLRs activated by bacterial
toxins, crystals, and danger associated danger patterns
assemble and oligomerize into a common structure that
collectively activates the caspase-1 cascade [37]. Once
activated, caspase-1 proteolytically cleaves the cytokine
precursor pro-IL-1β and releases the biologically active form of
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Figure 5.  Effect of anesthetics on LPS-induced IL-1β upregulation in BV-2, A-1, and THP-1 cells.  BV-2 microglial cells were
exposed to LPS (1 µg/ml) in the presence of the indicated concentrations of propofol (A) or isoflurane (B) for 4 hours. IL-1β mRNA
was assayed with real-time RT-PCR. Data are presented as mean ± SD (n = 3). A-1 astrocytic cells, were exposed to LPS (1 µg/ml)
in the presence of the indicated concentrations of pentobarbital for 4 hours. Human acute monocytic leukemia cells, or THP-1 cells,
were exposed to LPS (1 µg/ml) in the presence of the indicated concentrations of pentobarbital or isoflurane for 4 hours. IL-1β
expression levels were normalized to that of 18S and expressed relative to the control mean. *P < 0.05 versus control, N.S., not
significant (Mann–Whitney U-test).
doi: 10.1371/journal.pone.0082930.g005
Anesthetics Inhibit IL-1β Expression in Glia
PLOS ONE | www.plosone.org 8 December 2013 | Volume 8 | Issue 12 | e82930
Figure 6.  Effect of isoflurane on LPS-induced IL-1β expression in mice, and plasma adrenocorticotropic hormone (ACTH)
levels.  Ten-week-old BALB/c mice were exposed to 0.5% isoflurane for 4 hours after LPS treatment (5 mg/kg) (n = 6). IL-1β mRNA
in the hypothalamus (A) and cortex (B) was assayed with real-time RT-PCR analysis. IL-1β expression levels were normalized to
that of 18S and expressed relative to the mean of control mice. IL-1β protein concentration (pg/ml) in the brain (C) and plasma (D)
was quantified with ELISA. Data are presented as mean ± SD. Serum ACTH concentration (pg/ml) was quantified with ELISA. Data
are presented as mean ± SEM. *P < 0.05 versus control; N.S., not significant (Mann–Whitney U-test).
doi: 10.1371/journal.pone.0082930.g006
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IL-1β [37]. In our experiments, immunoblot analysis using the
whole cell lysate of glial cells detected the precursor for IL-1β,
which has a molecular weight of 32 kd. IL-1β in the supernatant
of glial cell culture medium, which is considered the mature
form, was significantly suppressed by the anesthetics.
Therefore, anesthetic inhibition of IL-1β was not limited to the
transcriptional level, although the effect of anesthetics on
inflammasome activity is yet to be determined.
Proinflammatory cytokines produced by glial cells can have
both beneficial and harmful effects [31]. Glial cells can produce
cytokines, reactive oxygen radicals, and nitric oxide in
response to ischemic, traumatic, and infectious insults, and in
cases when such inflammatory response is excessive or
prolonged, the disease process is exaggerated [31].
Suppressing the inflammatory responses of glial cells
attenuates some of these pathological conditions [38,39]. In
contrast, proinflammatory cytokines produced by glial cells in
the acute phase could be necessary for mammals to respond
rapidly to an infection [31]. That is, HPA axis activation and
subsequent glucocorticoid production are critical for survival as
they regulate the immune system’s responses [40]. Recently,
proinflammatory cytokines, particularly IL-1β secreted by glial
cells, are considered essential for HPA axis response [41].
Therefore, we investigated whether anesthetics affected IL-1β
expression in the mouse brain 4 h after LPS treatment. We
observed IL-1β expression in the hypothalamus and cortex was
significantly suppressed with isoflurane exposure. Interestingly,
serum IL-1β concentration was not affected by isoflurane,
although brain IL-1β concentration was significantly lowered.
This finding may be attributed to the difference between
microglia and monocytes in their responses to LPS. The LPS-
induced IL-1β upregulation observed in THP-1 cells was not as
distinct as the response observed in BV-2 cells. In contrast,
serum ACTH level was increased with LPS treatment, but was
suppressed with isoflurane. This result demonstrates that
isoflurane affects the HPA axis response. HPA axis
contributions to the stress response are essential in the acute
phase of infection [40,42,43]. Therefore, our result suggests
that anesthetics may have a great impact on the clinical course
of septic patients. In fact, septic patients commonly need
sedative drugs during critical care. However, according to the
recent reports, anesthetics used for such sedation may worsen
the prognosis for these critically ill patients [44]. The precise
mechanisms underlying the worsened prognosis are largely
unknown. Considering the pivotal role the HPA axis plays in the
stress response, anesthetics may cause adverse effects by
suppressing corticosterone production. Further in vivo studies
using propofol or midazolam are required to examine this topic
further. On the other hand, prolonged glial cell activation and
proinflammatory cytokine production can cause chronic
neuroinflammation and promote neuronal injury, and
pharmacological inhibition of microglia can reduce LPS-
induced neurological dysfunction and brain injury [39,45]. In the
present study, we examined these cells for a relatively short
time, whereas anesthetics are administered over longer
periods in clinical settings. Therefore, in such situations, the
anesthetic inhibition of glial cell IL-1β secretion may provide
beneficial results such as cognitive function improvement.
In conclusion, we found that anesthetics, including
isoflurane, pentobarbital, midazolam, ketamine, and propofol,
suppressed LPS-induced IL-1β expression in glial cells and the
BV-2 microglial cell line. However, IL-6 and TNF-α mRNA
expression was not suppressed. Anesthetics commonly
suppressed LPS-induced ERK 1/2 phosphorylation, but did not
affect NFκB or AP-1 activation. In the mouse experiments,
where LPS was injected intraperitoneally, isoflurane
suppressed brain IL-1β levels and plasma ACTH levels,
although IL-1β plasma concentration was not changed. Our
results indicate that general anesthetics inhibit LPS-induced
IL-1β upregulation in glial cells, particularly in microglia, and
affects HPA axis participation in the stress response.
Methods
Animals
This study (ID: Med Kyo 09504) was approved by the Animal
Research Committee of Kyoto University (Kyoto, Japan), and
all experiments were conducted in accordance with the
institutional and NIH guidelines for the care and use of
laboratory animals. All procedures were performed on
C57BL/6N mice purchased from Japan SLC Inc., Shizuoka,
Japan. Food and water were provided ad libitum, and the mice
were maintained under controlled environmental conditions
(24°C, 12-h light/dark cycles).
Drugs and chemicals
Isoflurane and pentobarbital were obtained from Dainippon
Sumitomo Pharma Co., Ltd., Osaka, Japan. 2,6-
Diisopropylphenol (propofol), midazolam, PMA, LPS, E. coli
055:B5, and PD98059 were obtained from Sigma, St. Louis,
MO, USA. Ketamine was purchased from Sankyo Co., Ltd.,
Tokyo, Japan.
Cell culture
Primary cultures of cerebral glial cells were prepared from 1-
or 2-day-old C57BL/6N CrSlc mice according to a previously
described method [46]. Brains were removed from mice under
sterile conditions, and the meninges were carefully removed.
The tissue was dissociated by passing it through a 320-µm
nylon mesh using a rubber policeman. After washing with
Hanks’ balanced salt solution that contained DNaseI, the cells
were suspended and passed through a 100-µm nylon mesh.
Next, the cells were plated on a plastic culture flask (density of
two brains per flask) in a 10-ml tissue culture medium. The
tissue culture medium contained Dulbecco’s modified Eagle’s
medium (DMEM; Gibco/BRL, Gaithersburg, MD, USA)
supplemented with 10% fetal bovine serum (FBS), 100 U/ml
penicillin, and 0.1 mg/ml streptomycin. The cultures were
maintained in a humidified atmosphere of 5% CO2 in air at
37°C. The medium was changed after 3 days and then twice
weekly thereafter. At the first medium change, the flasks were
vigorously shaken to remove oligodendrocytes and their
precursors. All in vitro experiments were performed with 14-
day-old cells. The immortalized mouse microglial cell line BV-2
were cultured in DMEM containing 10% FBS and antibiotics
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(100 IU/ml penicillin and 100 µg/ml streptomycin) at a density
not exceeding 5 × 105 cells/ml, and maintained at 37°C in a
humidified incubator with 5% CO2 in air. The BV-2 cell is
commonly used cell line for the experiment of microglia, but not
commercially available. The cell was originally developed by
Dr. V. Bocchini (University of Perugia, Perugia, Italy), and it
was generously provided to us by Dr. Inoue (Kyusyu University,
Fukuoka, Japan). The immortalized murine BV-2 cell line is
supposed to exhibit both the phenotypic and functional
properties of the reactive microglia cells [47].
The A1 astrocyte cell line was purchased from Japanese
Collection of Research Bioresources and cultured in DMEM
supplemented with 10% FCS, 100 U/ml penicillin, and 0.1
mg/ml streptomycin, and maintained at 37°C in a humidified
incubator with 5% CO2 in air. THP-1 human myeloid leukemia
cells (a gift from Dr. Kume at Kyoto University) were
maintained in a RPMI 1640 supplemented with 10% FBS, 100
U/ml penicillin, and 100 g/ml streptomycin at 37°C in a
humidified incubator with 5% CO2 in air. To promote
differentiation to macrophages, THP-1 cells were exposed to
PMA at a final concentration of 50 nM for 12 h. The cells then
were seeded in six-well plates before being subjected to
treatments. In our pilot studies using trypan blue exclusion dye
assay, we observed no significant cell death at several time
points or with varying doses of LPS and anrsthetics.
Isoflurane exposure
Isoflurane exposure was performed as previously described
[15]. In brief, cell dishes were maintained in airtight chambers
housed within a water jacket incubator maintained at 37°C. An
in-line calibrated anesthetic agent vaporizer was used to
deliver isoflurane to the gas phase of the culture wells. Air was
administered at a flow rate of 3 l/min, until the appropriate
effluent anesthetic concentration was achieved. Effluent
isoflurane concentration was continuously monitored through a
sampling port connected to an anesthetic agent analyzer
(Capnomac Ultima; Datex-Ohmeda, Helsinki, Finland).
Reverse transcription and real-time quantitative
polymerase chain reaction
RNA was isolated from cells or brains using the FastPure™
RNA Kit (Takara Bio, Inc., Shiga, Japan). First-strand synthesis
and real-time RT-PCR were performed using the One Step
SYBR™ PrimeScript™ RT-PCR Kit II (Takara Bio) according to
the manufacturer’s instructions. PCR was performed using the
Applied Biosystems 7300 Real-Time PCR System (Applied
Biosystems, Foster City, CA). All PCR primers, except 18S for
mouse and IL-1β and 18S for human, were purchased from
Invitrogen Corporation, Carlsbad, CA. Primer sequences were
as follows: IL-1β, 5′- CGACAAAATACCTGTGGCCT-3′
(forward) and 5′- TTCTTTGGGTATTGCTTGGG-3′ (reverse);
IL-6, 5′-GAAACCGCTATGAAGTTCCTCTCTG-3′ (forward) and
5′- TGTTGGGAGTGGTATCCTCTGTGA-3′ (reverse); TNF-α,
5′-GAAAAGCAAGCAGCCAACCA-3′ (forward) and 5′-
CGGATCATGCTTTCTGTGCTC -3′ (reverse) 18S for mouse,
IL-1β and 18S for human primers were purchased from Qiagen
(Valencia, CA) (Catalog numbers: 18S mouse: QT02448075;
IL-1β: QT00001568; 18S human: QT00199367). For each
target mRNA, the fold changes in expression were calculated
relative to 18S rRNA.
ELISA of IL-1β
Concentrations of IL-1β supernatants in glial cell cultures,
brains, and plasma of mice were determined using an ELISA
kit (R&D Systems Europe, Abingdon, UK). Samples were
prepared according to the manufacturer’s instructions. Some
modification was made with the brain analysis. In brief, the
entire brain was homogenized in phosphate-buffered saline
(PBS), centrifuged for 10 min at 5,000 ×g at 4°C, and
immediately frozen at −20°C. The brain homogenates were
assayed after two freeze–thaw cycles to break the cell
membranes.
Immunoblot assay
Whole cell lysates were prepared using ice-cold lysis buffer
[0.1% SDS, 1% Nonidet P-40 (NP-40), 5 mM EDTA, 150 mM
NaCl, 50 mM Tris-Cl (pH 8.0), 2 mM DTT, 1 mM sodium
orthovanadate, and Complete protease inhibitor (Roche
Diagnostic, Tokyo, Japan)] following a protocol described
previously [15]. The aliquots (100 µg protein) were fractionated
by sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS/PAGE) (7.5% gel) and subjected to an immunoblot assay
following a protocol described previously [48]. Primary
antibodies raised against IL-1β (#8689; Cell Signaling,
Stockholm, Sweden), GFAP (#3670; Cell Signaling), IBA-1
(ab107159; abcam, Cambridge, MA), β-actin (A5316; Sigma-
Aldrich, St. Louis), ERK 1/2 (#4696; Cell Signaling), phospho-
ERK1/2 (#9106; Cell Signaling), JNK (#9252; Cell Signaling),
phospho-JNK (#9255; Cell Signaling), p38 MAPK (#9212; Cell
Signaling), and phospho-p38 MAPK (#9211; Cell Signaling)
were used at a 1:1000 dilution. Horseradish peroxidase (HRP)-
conjugated sheep anti-mouse immunoglobulin G (IgG) (GE
Healthcare, Piscataway, NJ) or donkey anti-rabbit IgG
antibodies (GE Healthcare) also were used at a 1:1000 dilution.
The signal was detected with enhanced chemiluminescence
reagent (GE Healthcare).
Nuclear protein preparation and Trans-AM assay
Nuclear extracts were prepared from glial cells using a
nuclear extraction kit (Active Motif, Carlsbad, CA). Activation of
NF-κB and AP-1 was quantified using an ELISA-based assay
kit (Trans-AM; Active Motif). The assay was performed
following the manufacturer's instructions. Nuclear protein (25
µg) was incubated in a 96-well plate coated with
oligonucleotides containing NF-κB consensus site (5′-
GGGACTTTCC-3′) or a TPA-response element (TRE) (5′-
TGAGTCA-3′). NF-κB and AP-1 contained in nuclear extracts
bind specifically to this oligonucleotide during incubation for 2 h
at room temperature. The NF-κB p65 antibody or c-jun
antibody (100 µl, at 1:1000 dilution) was then added to each
well for 1.5 h followed by 100 µl of HRP-conjugated antibody
(1:1000 dilution) for 1 h. After adding 100 µl of developing
solution for up to 15 min and colorimetric reaction was stopped,
the NF-κB and AP-1 activity was determined by reading the
absorbance on a spectrophotometer at 450 nm with a
reference wavelength of 655 nm.
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Serum ACTH ELISA
Mice were injected intraperitoneally with LPS (5 mg/kg) or
saline between 0830 and 1100 h, and were sacrificed 4 h later.
Serum ACTH levels were measured using an ACTH kit per the
manufacturer’s instructions (MD bioproducts, MN). The minimal
detectable ACTH concentration was 0.22 pg/ml.
Statistical analysis
All data except plasma ACTH concentration are presented
as the mean ± SD. Plasma ACTH concentration is presented
as the mean ± SEM. Statistical significance was assessed by a
Mann–Whitney U-test for between group comparisons, and by
a Kruskal–Wallis H-test, followed by a Mann–Whitney U-test
with Bonferroni Correction for multiple comparisons.
Significance was defined by a P value of <0.05.
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